EP 258 | Q2 Performance Review | & our thoughts on Wolters kluwer, Novo Nordisk and UnitedHealth
In this week’s episode of Dividend Talk, we kick off with our Q2 performance review , looking at how our dividend portfolios fared, what we bought, sold, and learned over the past quarter. We also dive into three big names making headlines: Wolters Kluwer’s sharp share price drop and the fear of AI disruption,…